Orofaciodigital syndrome

From WikiMD's Medical Encyclopedia

Revision as of 06:25, 8 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Orofaciodigital syndrome
Synonyms Oral-facial-digital syndrome
Pronounce N/A
Specialty N/A
Symptoms Cleft palate, polydactyly, facial dysmorphism, dental anomalies
Complications Developmental delay, intellectual disability
Onset Congenital
Duration Lifelong
Types Type I, Type II, Type III, etc.
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, clinical examination
Differential diagnosis Orofacial cleft, Ellis-van Creveld syndrome
Prevention Genetic counseling
Treatment Symptomatic management, surgery
Medication None specific
Prognosis Variable, depends on type and severity
Frequency Rare
Deaths Rarely life-threatening


A group of genetic disorders affecting the development of the face, oral cavity, and digits


Orofaciodigital syndrome (OFD) refers to a group of rare genetic disorders characterized by malformations of the face, oral cavity, and digits. These syndromes are primarily inherited in an X-linked dominant pattern and are known for their clinical variability. The most well-known type is Orofaciodigital syndrome type I, but there are several other types, each with distinct genetic causes and clinical features.

Classification[edit]

Orofaciodigital syndromes are classified into several types based on their genetic and phenotypic characteristics. The most common types include:

  • Orofaciodigital syndrome type I (OFD1): This is the most prevalent form and is caused by mutations in the OFD1 gene located on the X chromosome. It is characterized by facial dysmorphisms, oral cavity anomalies, and digital malformations.
  • Orofaciodigital syndrome type II (Mohr syndrome): This type is autosomal recessive and involves similar features to OFD1 but with additional anomalies such as polydactyly.
  • Orofaciodigital syndrome type III (Sugarman syndrome): This type includes features like cleft lip and palate, and is also autosomal recessive.

Clinical Features[edit]

The clinical presentation of orofaciodigital syndromes can vary widely, but common features include:

Facial Anomalies[edit]

  • Hypertelorism (increased distance between the eyes)
  • Broad nasal bridge
  • Cleft lip and/or palate

Oral Cavity Anomalies[edit]

  • Lobulated tongue
  • Multiple oral frenula
  • Clefts or pseudoclefts in the alveolar ridge

Digital Anomalies[edit]

  • Brachydactyly (short fingers)
  • Syndactyly (fusion of fingers or toes)
  • Polydactyly (extra fingers or toes)

Genetics[edit]

Orofaciodigital syndromes are primarily caused by mutations in genes that are involved in the development of the face, oral cavity, and digits. The OFD1 gene, responsible for type I, encodes a protein that is involved in the formation of primary cilia, which are essential for cell signaling during embryonic development.

Diagnosis[edit]

Diagnosis of orofaciodigital syndrome is based on clinical evaluation, family history, and genetic testing. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes.

Management[edit]

There is no cure for orofaciodigital syndromes, and treatment is primarily supportive and symptomatic. Management may include:

  • Surgical correction of cleft lip and palate
  • Orthodontic treatment for dental anomalies
  • Physical therapy for motor skills development

Prognosis[edit]

The prognosis for individuals with orofaciodigital syndrome varies depending on the type and severity of the condition. Early intervention and supportive care can improve quality of life and functional outcomes.

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.